The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prototype precision oncology learning ecosystem: Norwegian precision cancer medicine implementation initiative.
 
Kjetil Tasken
Stock and Other Ownership Interests - Ledidi; Serca Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Inve2 Tech Transfer Office of Oslo University Hospital; Serca Pharmaceuticals
 
Hege Russnes
Honoraria - AstraZeneca (Inst); AstraZeneca (Inst); InCyte (Inst); Merck (Inst); Pfizer (Inst); Pfizer (Inst); Roche (Inst)
Research Funding - Foundation Medicine (Inst)
 
Aslaug Helland
Research Funding - Foundation Medicine; Illumina; Incyte; Lilly; Novartis; Roche
 
Eline Aas
No Relationships to Disclose
 
Line Bjørge
No Relationships to Disclose
 
Egil Støre Blix
No Relationships to Disclose
 
Espen Enerly
No Relationships to Disclose
 
Gro Live Fagereng
No Relationships to Disclose
 
Åsmund Flobak
Honoraria - Bayer; Novartis; Pfizer
Consulting or Advisory Role - Novartis
Speakers' Bureau - Bayer; Pfizer
Research Funding - Novartis (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - Computational algorithms for drug response prediction, patent pending
 
Bjornar Gilje
No Relationships to Disclose
 
Bjorn T. Gjertsen
Leadership - Alden Cancer Therapy II; Kinn Therapeutics
Stock and Other Ownership Interests - Alden Cancer Therapy II; Aprea Therapeutics; BerGenBio; Immunicum; Kinn Therapeutics
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; BerGenBio; Jazz Pharmaceuticals; MSD; Novartis; Pfizer; Seagen
Speakers' Bureau - Genzyme; Novartis; Oslo Cancer Cluster; Pfizer
Research Funding - Boehringer Ingelheim
Patents, Royalties, Other Intellectual Property - Alden Cancer Therapy II patent application in relation to CryoIT trial.
Travel, Accommodations, Expenses - AROG; Astellas Pharma; Novartis; Seagen
 
Tormod Kyrre Guren
No Relationships to Disclose
 
Jutta Heix
No Relationships to Disclose
 
Eivind Hovig
No Relationships to Disclose
 
Randi Hovland
No Relationships to Disclose
 
Per Eystein Lonning
No Relationships to Disclose
 
Per Magnus Maehle
No Relationships to Disclose
 
Hilde Loge Nilsen
No Relationships to Disclose
 
Steinar Osterbo Thoresen
Employment - Merck KGaA
Leadership - Merck KGaA
 
Sigbjørn Smeland
No Relationships to Disclose